The size of the CD11c+HLA-DRhi/low mDC population of DLE patients was 1.4-fold greater compared to that of DM patients (P > 0.05) and 3.1-fold greater than that of controls (P > 0.05) (Figure 6B). This evidence concerns the gene ITGAX and dermatomyositis.